Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Regulatory News (IBT)

Share Price Information for Int.biotech. (IBT)

Share Price is delayed by 15 minutes
Get Live Data
990.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 10.00 (1.016%)
Market Cap: £315.10m
IBT Live PriceLast checked at - London Stock Exchange

Intraday Int.biotech. Share Chart

Dividend Declaration

1 Jul 2025 07:00

RNS Number : 0665P
Intl. Biotechnology Trust PLC
01 July 2025
 

1 July 2025

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

 

Second interim dividend for the year ending 31 August 2025

 

At the Annual General Meeting of International Biotechnology Trust plc (the "Company") held on 9 December 2024, shareholders approved the Company's dividend policy of making dividend payments, equivalent to 4% of the Company's net asset value as at the last day of the preceding financial year (31 August 2024), through two equal semi-annual distributions.

 

The Directors have declared the payment of a second interim dividend of 16.17 pence per ordinary share for the year ending 31 August 2025.

 

In addition, the Company paid the first interim dividend of 15.56 pence per ordinary share for the year ending 31 August 2025 on 24 January 2025.

 

As at 27 June 2025, the latest practicable date prior to publication of this announcement, an annual dividend of 31.73 pence per share represents a yield of 5.40% calculated with reference to the Company's closing share price of 588 pence on 27 June 2025.

  

Ex-dividend date:

24 July 2025

Record date:

25 July 2025

Payment date:

22 August 2025

Dividend per share:

16.17 pence

 

 

Enquiries:

Kerry Higgins

Schroder Investment Management Limited

Tel: 020 7658 6000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVFMMFTMTTJBPA
Date   Source Headline
22nd Oct 202511:40 amRNSNet Asset Value(s)
21st Oct 20255:40 pmRNSTransaction in Own Shares
21st Oct 202511:49 amRNSNet Asset Value(s)
20th Oct 202511:56 amRNSNet Asset Value(s)
17th Oct 20255:24 pmRNSTransaction in Own Shares
17th Oct 202511:49 amRNSNet Asset Value(s)
16th Oct 202511:19 amRNSNet Asset Value(s)
15th Oct 20255:31 pmRNSTransaction in Own Shares
15th Oct 202511:43 amRNSNet Asset Value(s)
14th Oct 202511:48 amRNSNet Asset Value(s)
13th Oct 202511:59 amRNSNet Asset Value(s)
10th Oct 202511:25 amRNSNet Asset Value(s)
9th Oct 20255:05 pmRNSTransaction in Own Shares
9th Oct 20252:45 pmRNS-RNovo Nordisk to acquire portfolio company Akero
9th Oct 202511:21 amRNSNet Asset Value(s)
8th Oct 202511:49 amRNSNet Asset Value(s)
7th Oct 20255:37 pmRNSTransaction in Own Shares
7th Oct 202511:35 amRNSNet Asset Value(s)
7th Oct 20257:00 amRNSCompliance with Market Abuse Regulation
6th Oct 20255:15 pmRNSTransaction in Own Shares
6th Oct 202511:53 amRNSNet Asset Value(s)
3rd Oct 20255:06 pmRNSTransaction in Own Shares
3rd Oct 202511:02 amRNSNet Asset Value(s)
2nd Oct 202510:34 amRNSNet Asset Value(s)
2nd Oct 20257:00 amRNSPartnership Agreement with Schroders Capital
1st Oct 20255:38 pmRNSTransaction in Own Shares
1st Oct 20251:56 pmRNSTotal Voting Rights
1st Oct 202510:36 amRNSNet Asset Value(s)
30th Sep 202510:52 amRNSNet Asset Value(s)
29th Sep 20255:14 pmRNSTransaction in Own Shares
29th Sep 20251:16 pmRNS-RGenmab to acquire IBT portfolio company Merus
29th Sep 202510:43 amRNSNet Asset Value(s)
26th Sep 202510:28 amRNSNet Asset Value(s)
25th Sep 20255:19 pmRNSTransaction in Own Shares
25th Sep 202510:46 amRNSNet Asset Value(s)
24th Sep 20254:57 pmRNSTransaction in Own Shares
24th Sep 202510:33 amRNSNet Asset Value(s)
23rd Sep 20255:22 pmRNSTransaction in Own Shares
23rd Sep 202510:47 amRNSNet Asset Value(s)
22nd Sep 20252:36 pmRNS-RPfizer agrees to acquire portfolio company Metsera
22nd Sep 202510:23 amRNSNet Asset Value(s)
19th Sep 202510:57 amRNSNet Asset Value(s)
18th Sep 20255:45 pmRNS-RAcquisition of portfolio company 89Bio by Roche
18th Sep 202510:06 amRNSNet Asset Value(s)
17th Sep 20255:23 pmRNSTransaction in Own Shares
17th Sep 202510:27 amRNSNet Asset Value(s)
16th Sep 20255:54 pmRNSTransaction in Own Shares
16th Sep 202510:41 amRNSNet Asset Value(s)
15th Sep 202510:26 amRNSNet Asset Value(s)
12th Sep 202510:12 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.